Avestria Ventures

What is Avestria Ventures?

Avestria Ventures is a venture capital firm specializing in seeding and developing early-stage investments within the women's health and life science sectors. Their focus is on harnessing innovative technologies and solutions that can significantly improve patient care.

With an investment range from a minimum of $100,000 to a maximum of $5,000,000, Avestria Ventures typically targets investment opportunities where they can contribute $1,500,000, known as their investment 'sweet spot.' Their investment thesis emphasizes support for BioTech, FinTech and Financial Services, HealthTech and Fitness, Medical Devices and Hospital Services, Healthcare and Wellness, and Consumer-facing sectors.

Avestria Ventures particularly specializes in Seed and Series A financing rounds.

They manage assets worth $100,000,000, with a strategic approach shaped by their deep industry experience in both medical and operational domains. The fund's leadership includes Tracy Dooley, a partner with an extensive background in biomedical engineering and healthcare M&A, who possesses a strong commitment to advancing digital health innovations.

Beyond her role at Avestria, Tracy Dooley has advised organizations ranging from startups to the Novartis Digital Accelerator Lab and the Bill and Melinda Gates Foundation, demonstrating her broad expertise and influential network in the industry. Avestria Ventures not only brings capital but also strategic insights and a commitment to fostering the growth of companies addressing critical needs in healthcare, particularly those improving lives through science and technology.